Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pretreatment Identification of 90-Day Readmission Among Heart Failure Patients Receiving Aquapheresis Treatment

Deya Alkhatib, Ibrahim Karabayir, Issa Pour-Ghaz, Sania Khan, Linda Hart, Megan Cease, View ORCID ProfileJohn L Jefferies, Oguz Akbilgic
doi: https://doi.org/10.1101/2023.05.05.23289603
Deya Alkhatib
aThe University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN, 38163, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dalkhati{at}uthsc.edu
Ibrahim Karabayir
bWake Forest School of Medicine – Section of Cardiovascular Medicine, Winston-Salem, NC, 27157, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Issa Pour-Ghaz
aThe University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN, 38163, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sania Khan
aThe University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN, 38163, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Hart
cSenior Clinical Education Manager – Nuwellis, Eden Prairie, MN, 55344, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan Cease
dVice President of Clinical Research – Nuwellis, Plymouth, MN, 55446, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L Jefferies
aThe University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN, 38163, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John L Jefferies
Oguz Akbilgic
bWake Forest School of Medicine – Section of Cardiovascular Medicine, Winston-Salem, NC, 27157, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND The use of traditional models to predict heart failure (HF) has limitations in preventing HF hospitalizations. Artificial intelligence (AI) and machine learning (ML) in cardiovascular medicine only have limited data published regarding HF populations, with none assessing the favorability of decongestive therapy aquapheresis (AQ). AI and ML can be leveraged to design non-traditional models to identify those who are at high risk of HF readmissions.

OBJECTIVES This study aimed to develop a model for pretreatment identification of risk for 90-day HF events among HF patients who have undergone AQ.

METHODS Using data from the AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial, we designed a ML-based predictive model that can be used before initiating AQ to anticipate who will respond well to AQ and who will be at high risk of future HF events.

RESULTS Using ML we identified the top ten predictors for 90-day HF events. Interestingly, the variable for ‘intimate relationships with loved ones’ strongly predicted response to therapy. This ML-model was more successful in predicting the outcome in HF patients who were treated with AQ. In the original AVOID-HF trial, the overall 90-day HF event rate in the AQ arm was 32%. Our proposed predictive model was accurate in anticipating 90-day HF events with better statistical accuracy (area under curve 0.88, sensitivity 80%, specificity 75%, negative predictive value 90%, and positive predictive value 57%).

CONCLUSIONS ML can help identify HF patients who will respond to AQ therapy. Our model can identify super-respondents to AQ therapy and predict 90-day HF events better than currently existing traditional models.

CONDENSED ABSTRACT Utilizing data from the AVOID-HF trial, we designed a ML-predictive model that can be used before initiating AQ to anticipate who will respond well to AQ and who will be at high risk of future HF events. Using ML, we identified the top 10 predictors for 90-day HF events. Our model can identify super-respondents to ultrafiltration therapy and predict 90-day HF events better than currently existing traditional models.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The research received no external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study used data from the AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial (all data was de-identified)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Footnotes

  • ↵* Co-first authorship

  • FUNDING: The research received no external funding.

  • AUTHOR DISCLOSURES: The authors declare no conflict of interest.

  • Short Tweet: Using #ArtificialIntelligence we identified the top 10 predictors for 90-day #HeartFailure events. This AI-model was more successful in predicting the outcome in HF patients treated with Aquapheresis. #CardioTwitter #JACCHF

  • Twitter Handles: @JACCJournals @HFSA @Deya_AlkhatibMD @akbilgicbmi

Data Availability

Any requests for data should be made in writing to the corresponding author, and the data will be provided in accordance with relevant institutional and ethical guidelines.

  • ABBREVIATIONS AND ACRONYMS

    ADHF
    acute decompensated heart failure
    AI
    artificial intelligence
    AQ
    Aquapheresis
    HF
    heart failure
    IV
    intravenous
    LD
    loop diuretic
    ML
    machine learning
    UF
    ultrafiltration
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted May 08, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Pretreatment Identification of 90-Day Readmission Among Heart Failure Patients Receiving Aquapheresis Treatment
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Pretreatment Identification of 90-Day Readmission Among Heart Failure Patients Receiving Aquapheresis Treatment
    Deya Alkhatib, Ibrahim Karabayir, Issa Pour-Ghaz, Sania Khan, Linda Hart, Megan Cease, John L Jefferies, Oguz Akbilgic
    medRxiv 2023.05.05.23289603; doi: https://doi.org/10.1101/2023.05.05.23289603
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Pretreatment Identification of 90-Day Readmission Among Heart Failure Patients Receiving Aquapheresis Treatment
    Deya Alkhatib, Ibrahim Karabayir, Issa Pour-Ghaz, Sania Khan, Linda Hart, Megan Cease, John L Jefferies, Oguz Akbilgic
    medRxiv 2023.05.05.23289603; doi: https://doi.org/10.1101/2023.05.05.23289603

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)